ScreenerHero

WINT Windtree Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · windtreetx.com
0.0003USD0.00%Mkt Cap: 10112 $P/E: 0.00

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap10.11K USD
Enterprise Value3.31M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.79M USD
Revenue/Share—
Last Price0.0003 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.22
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)323.19
EPS (Forward)-2.13
52W Range
0.00010% of range0.1900
52W High0.1900 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-17.88%
ROA-6.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.40M USD
CapEx (TTM)12.00K USD
FCF Margin—
FCF Yield-233812.54%
Net Debt3.28M USD
Net Debt/EBITDA-0.21
Balance Sheet
Debt/Equity0.18
Current Ratio0.33
Quick Ratio0.01
Book Value/Sh-0.34 USD
Cash/Share0.0060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 29, 2020
Splits
Last Split1:50
Split DateFeb 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.33.71M
Float33.71M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float3.96%
Short % Out.3.96%
Shares Short1.13M
Short (prev mo.)2.60M
Technical
SMA 500.0003 (+2.7%)
SMA 2000.0121 (-97.5%)
Beta1.73
S&P 52W Chg16.45%
Avg Vol (30d)30.45K
Avg Vol (10d)12.04K
Technical Indicators
RSI (14)31.4
MACD-0.0014
MACD Signal-0.0019
MACD Hist.+0.0005
BB Upper0.0007 USD
BB Middle0.0003 USD
BB Lower-0.0002 USD
BB Width314.63%
ATR (14)0.0004 USD
Vol Ratio (20d)0.00x